Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International Journal of Molecular Sciences, 21, 15, S. 5181-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2020
- Event
-
Veröffentlichung
- (who)
-
MDPI AG
- (when)
-
2020
- Creator
-
Puntigam, Lisa K.
Jeske, Sandra S.
Götz, Marlies
Greiner, Jochen
Laban, Simon
Theodoraki, Marie-Nicole
Döscher, Johannes
Weissinger, Stephanie E.
Brunner, Cornelia
Hoffmann, Thomas K.
Schuler, Patrick J.
- DOI
-
10.3390/ijms21155181
- URN
-
urn:nbn:de:bvb:384-opus4-1013927
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Puntigam, Lisa K.
- Jeske, Sandra S.
- Götz, Marlies
- Greiner, Jochen
- Laban, Simon
- Theodoraki, Marie-Nicole
- Döscher, Johannes
- Weissinger, Stephanie E.
- Brunner, Cornelia
- Hoffmann, Thomas K.
- Schuler, Patrick J.
- Universität Augsburg
- MDPI AG
Time of origin
- 2020
Other Objects (12)
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Immuntherapie des HNSCC: quo vadis?
Immunologische und molekulare Mechanismen bei Pathogenese und Therapie von Kopf-Hals-Karzinomen
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)
Immun-, radio- und chemotherapeutische Studien bei Kopf-Hals-Tumoren: Highlights der ASCO-Jahrestagung 2017
Immunotherapy for head and neck cancers: an update and future perspectives
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Vorbereitung zur Facharztprüfung HNO: Folge 65
Kommentar zu "Leitlinie zur Behandlung der Kopf-Hals-Karzinome – ein kritischer Blick"
HNSCC: tumour antigens and their targeting by immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Immuntherapie des HNSCC: quo vadis?
Immunologische und molekulare Mechanismen bei Pathogenese und Therapie von Kopf-Hals-Karzinomen
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)
Immun-, radio- und chemotherapeutische Studien bei Kopf-Hals-Tumoren: Highlights der ASCO-Jahrestagung 2017
Immunotherapy for head and neck cancers: an update and future perspectives
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Vorbereitung zur Facharztprüfung HNO: Folge 65
Kommentar zu "Leitlinie zur Behandlung der Kopf-Hals-Karzinome – ein kritischer Blick"
HNSCC: tumour antigens and their targeting by immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Immuntherapie des HNSCC: quo vadis?
Immunologische und molekulare Mechanismen bei Pathogenese und Therapie von Kopf-Hals-Karzinomen
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)
Immun-, radio- und chemotherapeutische Studien bei Kopf-Hals-Tumoren: Highlights der ASCO-Jahrestagung 2017
Immunotherapy for head and neck cancers: an update and future perspectives
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Vorbereitung zur Facharztprüfung HNO: Folge 65
Kommentar zu "Leitlinie zur Behandlung der Kopf-Hals-Karzinome – ein kritischer Blick"
HNSCC: tumour antigens and their targeting by immunotherapy